You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTMX Sale Disclosure
Ogden Christopher · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$4.95K
Ogden Christopher Chief Financial Officer
CTMX
CytomX Therapeutics
CTMX
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
CTMX daily price context
Close on/before transaction
$3.04
Jun 15, 2026
First close after public filing
$2.95
Jun 18, 2026
30-day return after filing
+22.71%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,624 shares @ $3.05
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001610717-26-000229
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$4.95K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytomx Therapeutics, Inc. CTMX Current | Sale | Jun 15, 2026 | $4.95K |